Take a look at the companies making headlines in midday trading. Hims & Hers — Shares of the telemedicine startup fell more than 10% after the U.S. Food and Drug Administration said there is no longer a shortage of the active ingredients in Eli Lilly’s Mounjaro and weight-loss drug Zepbound. Hims & Hers offers GLP-1 injections. Vertex Pharmaceuticals — Shares fell about 13% after the drugmaker released results from a Phase 2 study of Suzetrigine. The study found that subjects who received a placebo showed “similar within-group decreases in pain rating scales,” but the company said it plans to move the drug to a Phase 3 trial. Palantir Technologies — Palantir shares rose 4% after the company said it extended a long-term partnership with the U.S. Army worth $400.7 million for up to four years. Its total available cap is $618.9 million. Darden Restaurants — Darden shares rose more than 15% after reporting better-than-expected same-store sales growth at Olive Garden and LongHorn Steakhouse, putting the stock on track for its best day of 2020. The company also raised its full-year revenue guidance. Revenue is now expected to be $12.1 billion, up from the previous forecast of $11.8 billion to $11.9 billion. Accenture — Shares of the IT services management company rose about 7%. Accenture beat its fiscal first-quarter revenue forecast and raised its full-year guidance, saying it now expects revenue to grow 4% to 7%, compared with its previous forecast of 3% to 6%. Micron Technology — Shares of Micron Technology fell more than 16% after the chipmaker issued weaker-than-expected fiscal second-quarter guidance, putting the stock on track for its worst day since March 2020. Sanjay Mehrotra said its “consumer-oriented market is softening in the near term” and the company expects to resume growth in the second half of this fiscal. Lennar — Shares of Lennar fell 5% after the homebuilder’s fiscal first-quarter profit fell short of analysts’ expectations. Hurt by rising mortgage rates, Lennar reported earnings of $4.06 a share on revenue of $9.95 billion, while analysts polled by FactSet had forecast earnings of $4.15 a share on revenue of $10.06 billion. CarMax — Shares rose more than 2% after the company reported better-than-expected earnings results. In the third quarter, CarMax earned 81 cents per share on revenue of $6.22 billion. Analysts polled by FactSet expected earnings of 62 cents per share on revenue of $6.05 billion. Innodata — The data engineering stock jumped 14% after Wedbush announced an outperform. The company says it can win in the field of customized large-scale language models for artificial intelligence. Conagra Brands — The packaged foods company lowered its fiscal year forecast, sending shares down about 2%. ConAgra now expects its fiscal year adjusted earnings to be in the range of $2.45 to $2.50 per share, below previous guidance of $2.60 to $2.65 per share and the FactSet consensus of $2.58 per share. ConAgra still posted strong fiscal second-quarter adjusted profit and revenue results, beating the FactSet consensus. MicroStrategy, Coinbase – Cryptocurrency-related stocks fell with Bitcoin prices. MicroStrategy fell 6% and Coinbase fell 2.9%. Robinhood shares fell 1.6%. Lamb Weston — Shares of Lamb Weston plunged nearly 22% after the frozen potato maker reported disappointing quarterly results and lowered its adjusted profit forecast for fiscal 2025. Lamb Weston reported adjusted earnings of 66 cents per share on revenue of $1.60 billion, while analysts polled by FactSet expected earnings of $1.01 per share on revenue of $1.67 billion. Lamb Weston also replaced its chief executive on Thursday. The company has been under pressure from activist investor Jana Partners, which has also been pushing Lamb Weston to sell itself. —CNBC’s Alex Harring, Samantha Subin, Yun Li, Lisa Han, Sean Conlon and Michelle Fox contributed reporting.
